Welkin Health, a patient relationship management software company, today announced $17.5 million in Series B funding led by Altos Ventures. Existing investors, Thrive Capital, Red Swan Ventures, and Asset Management Ventures also contributed to the round, which brings Welkin’s total funding to $30 million. Welkin’s patient relationship management software is designed to meet the unique patient care needs of its customers, which include medical device companies, payers, providers, and disease management service providers. The platform enables health care teams to work effectively and improve health outcomes. “Over the past two years, we’ve transformed how customers use our platform,” says Chase Hensel, CEO and co-founder of Welkin Health. “Our APIs and Workshop tool enable customers to launch quickly, to flexibly plug us into their tech stack, and to make changes to their care programs over time. We’re excited to work with Altos to continue our mission of helping health care organizations create meaningful patient relationships at scale.”
Thrive Capital leads healthtech startup Welkin Health’s $8 million Series A
Digital patient relationship platform Welkin Health has landed $8 million in Series A financing, led by Josh Kushner’s Thrive Capital. This now brings the total in the VC piggy bank to $12 million for the company. Welkin launched in 2013 as a digital monitoring system for diabetics. It joined Rock Health in 2014 to create a disease management platform with robotic coaching tools similar to Livongo Health and other chronic condition management platforms. Welkin launched its first major pilot with Humana’s Innovation Group in 2015, helping to put the startup in a recognizable position among competitors.